Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Principal Investigator
Name
Jianjun Zhang
Institution
Indiana University
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
2011-0121
Initial CDAS Request Approval
Oct 6, 2011
Title
Dietary Intake of Vitamin K and Risk of Prostate Cancer
Summary
Vitamin K has two forms that naturally occur in foods, i.e., phylloquinone (vitamin K1) and menaquinone (vitamin K2). While phylloquinone is abundant in green leafy vegetables and some vegetable oils, menaquinone is synthesized by microflora in the gut and is primarily derived from fermented food products (e.g. cheese). Although vitamin K is well known for its essential function in blood coagulation, substantial experimental evidence indicates that it also possesses an anticarcinogenic effect on a variety of cancer cell lines, including prostate cancer cells. To date, however, few epidemiologic studies have investigated the association between vitamin K intake and prostate cancer risk. Clearly, there is a critical need to explore this association because lack of such knowledge could hinder the elucidation of the etiology of prostate cancer and in turn the formulation of innovative measures for its primary prevention. We hypothesize that vitamin K is inversely associated with prostate cancer risk. Our hypothesis is novel but biologically plausible. We propose to test this hypothesis among all men in the screening arm of the PLCO Cancer Screening Trial. We pursue the two specific aims. Specific Aim 1: Calculate dietary intakes of phylloquinone and menaquinone from completed food frequency questionnaires; and Specific Aim 2: Evaluate the association between dietary intakes of phylloquinone and menaquinone and risk of prostate cancer. The proposed research is significant because our expected results will contribute to an improved understanding of the etiology and prevention of prostate cancer.
Aims

Specific Am 1: Calculate dietary intakes of phylloquinone and menaquinone from completed food frequency questionnaires. Men in the screening (or intervention) arm responded to Dietary Questionnaire (DQX) and Dietary History Questionnaire (DHQ) at baseline (T0) and the third year visit (T3), respectively. Dietary intake of vitamin K will be calculated from both DQX and DHQ. Specific Aim 2: Evaluate the association between dietary intakes of phylloquinone and menaquinone and risk of prostate cancer. We hypothesize that dietary intakes of phylloquinone and menaquinone were inversely associated with prostate cancer risk.

Collaborators

Amanda Black (DCEG)
Ann Hsing (DCEG)
Lang Li (Indiana University)

Related Publications